11/21/201956 Listed Chinese Pharma Cos Had R&D Spending Above CNY 100M in 3Q...

11/21/2019NMPA Approves IND Application of MDI for Analgesic Penthrox

11/21/2019Fosun Pharma, MimiVax to Jointly Develop and Commercialize SurVaxM The...

11/20/2019WuXi STA Forms Strategic Partnership with Impact Therapeutics

11/20/2019Northeast Pharma under Anti-monopoly Investigation in Liaoning

11/20/2019State Council Orders Prioritized Purchase of GQCE Essential Drugs with...

11/20/2019Mundipharma Accused of Using Fake Doctors, Misleading Claims to Drive ...

11/19/2019Xian Janssen: Embrace Better Future with New Solutions

11/19/2019WuXi AppTec's LTD Expands Toxicology Facility in China

11/18/2019Novartis Closes Early Drug Discovery R&D Unit in China

11/18/2019Chinese Import of Medicines Up Only 1.6% in 3Qs/2019

11/18/2019Listed Chinese MedPharm Companies Report Slower Growth in Q3

11/16/2019Hua Medicine Stock Sheds 40% Over Efficacy Concerns of Its Novel Diabe...

11/16/2019RemeGen Announces Positive Results from Phase IIb Trial of SLE Drug

11/16/2019Recent Executive Moves

11/15/2019State Council Announces Promotion of Healthcare Reform Experience of F...

11/15/2019CDE Accepts Lilly's NDA for Verzenio (Abemaciclib)

11/13/2019Thermo Fisher Opens Customer Solution Center in China

11/13/2019China Issues the Provisions for Health Insurance Administration

11/13/2019Pharmaceutical Innovation in the APAC Region

11/13/2019LEO Pharma, HitGen to Develop Novel Class of Derma Drugs

11/13/2019Hua Medicine's Pivotal Phase III Monotherapy Trial of Dorzagliatin

11/13/2019As Trade War Continues, Pharma Companies Prepare for Alternatives

11/11/2019Chi-Med Announces NDA Acceptance for Novel Drug Surufatinib

11/11/2019CDE Extends Deadline for Public Comments on Nine Draft Documents

11/8/2019NDRC Issues the Work Plan for Building Regional Medical Centers

11/8/2019NHC Issues Notice to Establish National and Regional Mental Medicine+C...

11/7/2019Biogen and Samsung Expand Biosimilar Deal to Cover China and More Prod...

11/7/2019Tot Biopharm Raises $75.2M in Hong Kong IPO

11/7/2019Restrictions and Conflicts - Challenges Faced by Pharmaceutical Tradem...

Page:105/334 Total number of articles:9993: [First][<<] [103] [104] [105] [106] [107] [>>] [End]